Niagen Bioscience, Inc. (NAGE) — Stock Score Summary

Niagen Bioscience, Inc. (NAGE) has a MoatMap StockRank of 48/100 based on Quality (75/100), Value (38/100), and Momentum (22/100) factor scores. The current signal is HOLD. Niagen Bioscience, Inc. is a micro-cap healthcare company. This falls into the speculative biotech category, lacking the predictable characteristics of a quality compounder (asset-light, high ROIC, durable moat). There is no macro tailwind that creates an asymmetric opportunity for such a high-risk venture in our concentrated portfolio.

The ticker NAGE, listed as Niagen Bioscience, Inc. in the healthcare sector, does not correspond to a clearly identifiable publicly traded company. Therefore, a specific and factual company profile cannot be accurately generated at this time.

Key Financial Metrics

Price$3.84
Market Cap$306M
P/E (TTM)18.38
P/E (Forward)12.06
Price/Book3.73
Return on Equity27.1%
Return on Invested Capital16.5%
Debt/Equity3.13
Gross Margin64.3%
Operating Margin5.0%
Revenue Growth3.3%
Free Cash Flow$-2M

Niagen Bioscience, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Niagen Bioscience, Inc.’s (NAGE) StockRank?
MoatMap’s StockRank for Niagen Bioscience, Inc. (NAGE) is 48/100, with a Hold signal. It is a composite of Quality (75), Value (38), and Momentum (22) factor ranks across MoatMap’s 19,000+ stock universe.
Does Niagen Bioscience, Inc. have an economic moat?
Niagen Bioscience, Inc. (NAGE) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Niagen Bioscience, Inc. a buy, hold, or sell?
MoatMap’s current signal for Niagen Bioscience, Inc. (NAGE) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Niagen Bioscience, Inc. in?
Niagen Bioscience, Inc. (NAGE) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksNAGE deep dive reportAI ChampionsHow we score stocksSense-check another stock